Dennis A. Ausiello - 29 Jul 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Dennis A. Ausiello
Issuer symbol
RANI
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
02 Aug 2021, 19:39:07 UTC
Date Of Original Report
29 Jul 2021
Previous filing
19 Jul 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RANI Class A Common LLC Units 29 Jul 2021 Class A Common Stock 91,936 Direct F1, F2
holding RANI Stock Option (Right to Buy) 29 Jul 2021 Class A Common Stock 79,242 $9.45 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Class A Common LLC Units of Rani Therapeutics, LLC, a direct subsidiary of the Issuer. The Class A Common LLC Units are exchangeable for shares of Class A Common Stock on a one-for-one basis at the discretion of the holder, subject to certain exceptions, conditions and adjustments, and have no expiration date.
F2 This amendment is being filed to correctly reflect the shares held.
F3 The shares subject to the option vest as follows: 1/36th of the shares subject to the option vest monthly over three years from June 17, 2021.
F4 This amendment is being filed to correctly reflect the exercise price of the Stock Option.